CIK 0001022899
- Non-accelerated filer
- Smaller reporting company
Protagenic Therapeutics, Inc.new
Sign in to watch- Ticker
- PTIX
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 061390025
- Phone
- +1 212-994-8200
- Business address
- 149 FIFTH AVENUE, SUITE 500, NEW YORK, NY, 10010
- Former names
- Atrinsic, Inc., NEW MOTION, INC., MPLC, Inc., MILLBROOK PRESS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-25 | Stein Robert Benjamin Director | Grant or award · PTIX Common stock Options | +75,000 | $1.74 | $131K | 75,000 |
| 2020-02-21 | Stein Robert Benjamin Director | Grant or award · PTIX Common stock Options | +150,000 | 150,000 | ||
| 2017-10-16 | Stein Robert Benjamin Director | Grant or award · Non-Qualified Stock Options (Right to Buy() | +200,000 | 200,000 | ||
| 2016-06-17 | Stein Robert Benjamin Director | Grant or award | +40,000 | $1.25 | $50K | 240,000 |
Page 1 of 1 · 4 trades